Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have received chemotherapy to treat breast cancer and finished treatment at least 6 months ago
- People who have noticed concerns about their own memory or thinking since treatment
- People aged between 18 and 65 years
- People who are right-handed
Who may not be able to join:
- People who had a diagnosis of dementia before their cancer treatment
- People with other conditions affecting the brain or nervous system, including epilepsy or a history of seizures
- People with serious untreated medical conditions that a responsible doctor determines would prevent participation in the training
- People with a history of moderate to severe substance use disorder, as defined by a standard diagnostic guideline called the DSM-5
- People currently experiencing moderate to severe acute mental health conditions, as defined by the DSM-5
- People for whom a brain stimulation technique called tDCS would not be safe to use (confirm with trial site for details on what this includes)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Agnes Flöel, Prof., University Medicine Greifswald
Phone: 0049 3834 86 6815
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Working memory performance at post-assessment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.